Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3.
about
Myocardial diseases of animalsIntricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatmentContrasting features of T-lymphocyte-mediated diabetes in encephalomyocarditis virus-infected Balb/cBy and Balb/cCum mice.Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditisIn situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.Clinical and experimental aspects of viral myocarditis.Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivoTreatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies.Derivation and characterization of an efficiently myocarditic reovirus variant.Nitric oxide inhibition of coxsackievirus replication in vitro.Relevance of molecular mimicry in the mediation of infectious myocarditis.
P2860
Q27478460-90D9BD5C-DC7A-498C-8D23-86DF9D39CFCDQ35483420-71E4D05B-0CDF-44D1-8B88-F53688D36CB8Q35835669-23961804-7307-42A9-ADB9-2CAE59657487Q35836028-8040CDB7-43F2-4102-881B-011C69E5928DQ35836113-953836D7-1200-4083-9D2B-9D4186E72887Q35836596-7186407E-66BE-446A-B496-5E9C3906C287Q35843889-6EED8BF3-3F03-49DA-8481-E8DC825DAE44Q35849766-56E2B545-5238-4F3B-9A21-60AE7D72896CQ35856321-667D5098-B7DD-47B6-8E75-49FA4309C0D1Q35857932-A9124C7A-6BB2-41CA-AFCC-2A0356D2A00CQ36635072-FD8EEFDE-3DE4-4B98-A331-53039CB8F740Q36682025-794464DD-8D36-420D-804B-2DF43E31232FQ36820749-68BE53D5-417E-425D-8D8E-F2CB1FF0EF68Q36830998-17BC99AE-E506-444A-9B7B-261D6A37D914Q36831711-6CEFDFD5-F180-4F0A-9F25-BBBE110B128CQ37372893-EF3EEAC8-F9B3-4446-946E-6E2D75587A4CQ37619855-CC473DC3-04E6-4ADE-876A-33E77ABA682D
P2860
Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Differences in cytolytic T cel ...... oxsackievirus group B, type 3.
@ast
Differences in cytolytic T cel ...... oxsackievirus group B, type 3.
@en
type
label
Differences in cytolytic T cel ...... oxsackievirus group B, type 3.
@ast
Differences in cytolytic T cel ...... oxsackievirus group B, type 3.
@en
prefLabel
Differences in cytolytic T cel ...... oxsackievirus group B, type 3.
@ast
Differences in cytolytic T cel ...... oxsackievirus group B, type 3.
@en
P2860
P1476
Differences in cytolytic T cel ...... coxsackievirus group B, type 3
@en
P2093
P2860
P304
P407
P577
1983-03-01T00:00:00Z